Today is Monday, Aug. 3, 2020

Department of Internal Medicine

Hematology & Oncology

Photo of  Olugbenga Olowokure, MD

Olugbenga Olowokure, MD

Associate Professor of Medicine, Director, Inpatient Service UCMC

Clinical Interest

Hematology
Medical Oncology
Hematology and Oncology

Specialties

Hematology
Internal Medicine
Medical Oncology

Education/Credentials
  • Bachelor's Degree: University of Maiduguri
  • Residency: St. John's Episcopal Hospital
  • Fellowship: Mount Sinai School of Medicine
  • Medical Degree: University of Maiduguri
Contact Information
  • Vontz Center for Molecular Studies
  • 3125 Eden Avenue
  • ML 0562
  • Cincinnati, Ohio 45267
  • Office 513-558-2113
  • Fax 513-558-2124
  • Email olugbenga.olowokure@uc.edu
  • UC Institute Member Seal

Peer Reviewed Publications

Abou-Alfa, Ghassan K; Miksad, Rebecca A; Tejani, Mohamedtaki A; Williamson, Stephen; Gutierrez, Martin E; Olowokure, Olugbenga O; Sharma, Manish R; El Dika, Imane; Sherman, Matthew L; Pandya, Shuchi S 2019. A Phase Ib, Open-Label Study of Dalantercept, an Activin Receptor-Like Kinase 1 Ligand Trap, plus Sorafenib in Advanced Hepatocellular Carcinoma. The oncologist, 24 2, 161-e70

Ge, Chunmin; Vilfranc, Chrystelle L; Che, Lixiao; Pandita, Raj K; Hambarde, Shashank; Andreassen, Paul R; Niu, Liang; Olowokure, Olugbenga; Shah, Shimul; Waltz, Susan E; Zou, Lee; Wang, Jiang; Pandita, Tej K; Du, Chunying 2019. The BRUCE-ATR Signaling Axis Is Required for Accurate DNA Replication and Suppression of Liver Cancer Development. Hepatology (Baltimore, Md.), 69 6, 2608-2622

Kharofa, Jordan; Mierzwa, Michelle; Olowokure, Olugbenga; Sussman, Jeffrey; Latif, Tahir; Gupta, Anumeha; Xie, Changchun; Patel, Sameer; Esslinger, Hope; Mcgill, Brian; Wolf, Eric; Ahmad, Syed A 2019. Pattern of Marginal Local Failure in a Phase II Trial of Neoadjuvant Chemotherapy and Stereotactic Body Radiation Therapy for Resectable and Borderline Resectable Pancreas Cancer. American journal of clinical oncology, 42 3, 247-252

Sanoff, Hanna K; Goldberg, Richard M; Ivanova, Anastasia; O'Reilly, Seamus; Kasbari, Samer S; Kim, Richard D; McDermott, Ray; Moore, Dominic T; Zamboni, William; Grogan, William; Cohn, Allen Lee; Bekaii-Saab, Tanios S; Leonard, Gregory; Ryan, Theresa; Olowokure, Olugbenga O; Fernando, Nishan H; McCaffrey, John; El-Rayes, Bassel F; Horgan, Anne M; Sherrill, Gary Bradley; Yacoub, George Hosni; O'Neil, Bert H 2018. Multicenter, randomized, double-blind phase 2 trial of FOLFIRI with regorafenib or placebo as second-line therapy for metastatic colorectal cancer. Cancer, 124 15, 3118-3126

Wakefield, Connor; Mehta, Parinda A; Corathers, Sarah; Geller, James; Gelfand, Michael; Olowokure, Olugbenga; Marsh, Rebecca A 2018. A First Report of Secondary Hemophagocytic Lymphohistiocytosis Associated With Papillary Thyroid Carcinoma. Journal of pediatric hematology/oncology, 40 2, e97-e98

Kim, Young; Stahl, Christopher C; Makramalla, Abouelmagd; Olowokure, Olugbenga O; Ristagno, Ross L; Dhar, Vikrom K; Schoech, Michael R; Chadalavada, Seetharam; Latif, Tahir; Kharofa, Jordan; Bari, Khurram; Shah, Shimul A 2017. Downstaging therapy followed by liver transplantation for hepatocellular carcinoma beyond Milan criteria. Surgery, 162 6, 1250-1258

Wise-Draper, Trisha M; Moorthy, Ganesh; Salkeni, Mohamad A; Karim, Nagla Abdel; Thomas, Hala Elnakat; Mercer, Carol A; Beg, M Shalaan; O'Gara, Sue; Olowokure, Olugbenga; Fathallah, Hassana; Kozma, Sara C; Thomas, George; Rixe, Olivier; Desai, Pankaj; Morris, John C 2017. A Phase Ib Study of the Dual PI3K/mTOR Inhibitor Dactolisib (BEZ235) Combined with Everolimus in Patients with Advanced Solid Malignancies. Targeted oncology, 12 3, 323-332

Xia, Brent T; Fu, Baojin; Wang, Jiang; Kim, Young; Ahmad, S Ameen; Dhar, Vikrom K; Levinsky, Nick C; Hanseman, Dennis J; Habib, David A; Wilson, Gregory C; Smith, Milton; Olowokure, Olugbenga O; Kharofa, Jordan; Al Humaidi, Ali H; Choe, Kyuran A; Abbott, Daniel E; Ahmad, Syed A 2017. Does radiologic response correlate to pathologic response in patients undergoing neoadjuvant therapy for borderline resectable pancreatic malignancy? Journal of surgical oncology, 115 4, 376-383

Agarwal, Rishi; Sendilnathan, Arun; Siddiqi, Nabeela Iffat; Gulati, Shuchi; Ghose, Abhimanyu; Xie, Changchun; Olowokure, Olugbenga Olanrele 2016. Advanced biliary tract cancer: clinical outcomes with ABC-02 regimen and analysis of prognostic factors in a tertiary care center in the United States. Journal of gastrointestinal oncology, 7 6, 996-1003

Deeb, Ayham; Haque, Sulsal-Ul; Olowokure, Olugbenga 2015. Pulmonary metastases in pancreatic cancer, is there a survival influence? Journal of gastrointestinal oncology, 6 3, E48-51

O'Neil, B H; Scott, A J; Ma, W W; Cohen, S J; Leichman, L; Aisner, D L; Menter, A R; Tejani, M A; Cho, J K; Granfortuna, J; Coveler, A L; Olowokure, O O; Baranda, J C; Cusnir, M; Phillip, P; Boles, J; Nazemzadeh, R; Rarick, M; Cohen, D J; Radford, J; Fehrenbacher, L; Bajaj, R; Bathini, V; Fanta, P; Berlin, J; McRee, A J; Maguire, R; Wilhelm, F; Maniar, M; Jimeno, A; Gomes, C L; Messersmith, W A 2015. A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 26 9, 1923-9

O'Neil, B H; Scott, A J; Ma, W W; Cohen, S J; Leichman, L; Aisner, D L; Menter, A R; Tejani, M A; Cho, J K; Granfortuna, J; Coveler, L; Olowokure, O O; Baranda, J C; Cusnir, M; Phillip, P; Boles, J; Nazemzadeh, R; Rarick, M; Cohen, D J; Radford, J; Fehrenbacher, L; Bajaj, R; Bathini, V; Fanta, P; Berlin, J; McRee, A J; Maguire, R; Wilhelm, F; Maniar, M; Jimeno, A; Gomes, C L; Messersmith, W A 2015. A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 26 12, 2505

Rixe, Olivier; Puzanov, Igor; LoRusso, Patricia M; Cohen, Roger B; Morris, John C; Olowokure, Olugbenga O; Yin, Jian Y; Doroumian, Séverine; Shen, Liji; Olszanski, Anthony J 2015. Phase I dose-escalation study of cabazitaxel administered in combination with gemcitabine in patients with metastatic or unresectable advanced solid malignancies. Anti-cancer drugs, 26 7, 785-92

Yellu, Mahender R; Olowokure, Olugbenga 2015. Simultaneous presentation of pancreatic cancer in a genetically unrelated couple. BMJ case reports, 2015 ,

Yellu, Mahender; Deeb, Ayham; Olowokure, Olugbenga 2015. Overview of Recent Trends in the Management of Metastatic Anal Cancer. World journal of oncology, 6 1, 311-315

Beg, Muhammad Shaalan; Dwivedi, Alok Kumar; Ahmad, Syed Arif; Ali, Sadia; Olowokure, Olugbenga 2014. Impact of diabetes mellitus on the outcome of pancreatic cancer. PloS one, 9 5, e98511

Haque, Sulsal; Choe, Kyuran; Olowokure, Olugbenga 2014. Bilateral above knee amputations after prolonged exposure to sorafenib and trebananib. Journal of gastrointestinal oncology, 5 6, E109-12

Olowokure, Olugbenga; Qi, Xiaoyang 2014. Pancreatic cancer: current standards, working towards a new therapeutic approach. Expert review of anticancer therapy, 14 5, 495-7

Shi, Patricia Ann; Manwani, Deepa; Olowokure, Olugbenga; Nandi, Vijay 2014. Serial assessment of laser Doppler flow during acute pain crises in sickle cell disease. Blood cells, molecules & diseases, 53 4, 277-82

Singeltary, Brian; Ghose, Abhimanyu; Sussman, Jeffrey; Choe, Kyuran; Olowokure, Olugbenga 2014. Durable response with a combination of imatinib and sorafenib in KIT exon 17 mutant gastrointestinal stromal tumor. Journal of gastrointestinal oncology, 5 1, E27-9

Olowokure, Olugbenga; Torregroza-Sanchez, Maria Patricia; Bedoya-Apraez, Ivan Dario 2013. Gemcitabine plus Nab-Paclitaxel with chemoradiation in locally advanced pancreatic cancer (LAPC). Journal of gastrointestinal oncology, 4 2, E16-8

Grewal, Sanjeet S; McClaine, Rebecca J; Schmulewitz, Nathan; Alzahrani, Mohammed A; Hanseman, Dennis J; Sussman, Jeffery J; Smith, Milton; Choe, Kyuran A; Olowokure, Olugbenga; Mierzwa, Michelle; Ahmad, Syed A 2011. Factors associated with recidivism following pancreaticoduodenectomy. HPB : the official journal of the International Hepato Pancreato Biliary Association, 13 12, 869-75

Jeske, Stephanie; Tagawa, Scott T; Olowokure, Olugbenga; Selzer, Jodi; Giannakakou, Paraskevi; Nanus, David M 2010. Carboplatin plus paclitaxel therapy after docetaxel in men with metastatic castrate resistant prostate cancer. Urologic oncology, ,

Olowokure, O; Fishman, M; Cromwell, C; Aledort, L 2009. DDAVP for von Willebrand menorrhagia--severe hyponatraemia, haemolysis, seizure, coma.!! Caution. Haemophilia : the official journal of the World Federation of Hemophilia, 15 3, 837

Aisner D.; Bajaj R.; Baranda J.; Bathini V.; Berlin J.; Boles J.; Cho J.; Cohen D.; Cohen S.; Coveler L.; Cusnir M.; Fanta P.; Fehrenbacher L.; Gomes C.; Granfortuna J.; Jimeno A.; Leichman L.; Ma W.; Maguire R.; Maniar M.; McRee A.; Menter A.; Messersmith W.; Nazemzadeh R.; Olowokure O.; O'Neil B.; Phillip P.; Radford J.; Rarick M.; Scott A.; Tejani M.; Wilhelm F. 12-01-2015. A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine ve Annals of Oncology, 26 12, 2505

Bekaii-Saab T.; Cohn A.; El-Rayes B.; Fernando N.; Goldberg R.M.; Grogan W.; Horgan A.; Ivanova A.; Kasbari S.; Kim R.; McCaffrey J.; McDermott R.; Moore D.; Olowokure O.; O'Neil B.; O'Reilly S.; Ryan T.; Sanoff H.; Sherrill G.; Yacoub G. 10-01-2016. A multi-center, randomized, double-blind phase II trial of FOLFIRI + regorafenib or placebo for pati Annals of Oncology, 27 , vi153

Kamireddy C.; Olowokure O.; Yellu M. 09-27-2017. Pancreatic cancer epidemiology and environmental risk factors Current and Emerging Therapies in Pancreatic Cancer, , 1-22

Aisner D.L.; Bajaj R.; Baranda J.C.; Bathini V.; Berlin J.; Boles J.; Cho J.K.; Cohen D.J.; Cohen S.J.; Coveler A.L.; Cusnir M.; Fanta P.; Fehrenbacher L.; Gomes C.L.; Granfortuna J.; Jimeno A.; Ma W.W.; Maguire R.; Maniar M.; McRee A.J.; Menter A.R.; Messersmith W.A.; Nazemzadeh R.; Olowokure O.O.; O'Neil B.H.; Phillip P.; Radford J.; Rarick M.; Scott A.J.; Tejani M.A.; Wilhelm F. 06-18-2016. Erratum: A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemci Annals of Oncology, 27 6, 1180

Belyayeva I.; Braverman A.; Deitch J.; Gillette P.; Nehra A.; Olivier T.; Olowokure O.; Raftery T.; Weedon J. 06-01-2008. Perforator and axial venous insufficiency in sickle cell disease patients with and without leg ulcer Journal for Vascular Ultrasound, 32 2, 79-81

Agarwal R.; Ghose A.; Gulati S.; Olowokure O.; Sendilnathan A.; Siddiqi N.; Xie C. 01-01-2016. Advanced biliary tract cancer: Clinical outcomes with ABC-02 regimen and analysis of prognostic fact Journal of Gastrointestinal Oncology, 7 6, 996-1003

Atweh G.F.; Billett H.; Carullo V.; Chen G.; Cohen H.W.; Frenette P.S.; Huggins M.; Jang J.; Manwani D.; Olowokure O.; Serban S.; Shi P.A. 01-01-2015. Single-dose intravenous gammaglobulin can stabilize neutrophil Mac-1 activation in sickle cell pain American Journal of Hematology, 90 5, 381-385

Deeb A.; Haque S.; Olowokure O. 01-01-2015. Pulmonary metastases in pancreatic cancer, is there a survival influence? Journal of Gastrointestinal Oncology, 6 3, E48-E51

Deeb A.; Olowokure O.; Yellu M. 01-01-2015. Overview of recent trends in the management of metastatic anal cancer CJAM Canadian Journal of Addiction Medicine, 6 1, 311-315

Choe K.; Ghose A.; Olowokure O.; Singeltary B.; Sussman J. 01-01-2014. Durable response with a combination of imatinib and sorafenib in KIT exon 17 mutant gastrointestinal Journal of Gastrointestinal Oncology, 5 1,

Choe K.; Haque S.; Olowokure O. 01-01-2014. Bilateral above knee amputations after prolonged exposure to sorafenib and trebananib Journal of Gastrointestinal Oncology, 5 6, E109-E112

Bedoya-Apraez I.; Olowokure O.; Torregroza-Sanchez M. 01-01-2013. Gemcitabine plus nab-paclitaxel with chemoradiation in locally advanced pancreatic cancer (LAPC) Journal of Gastrointestinal Oncology, 4 2,

Abstract Publications

OO Olowokure, Beg MS, S Ali, A Tandra, MM Safa, K Havlin, SA Ahmad 2010. Is Diabetes Mellitus Associated with Worse Outcomes in Pancreatic Cancer ASCO, ,

OO Olowokure, Jeske S, Tagawa St, Selzer J, Giannakakou P, Nanus DM 05-2010. Carboplatin plus Paclitaxel Therapy After Docetaxel in Men With Metastatic Castrate Resistant Prostate Cancer , ,

OO Olowokure, PA Shi, JE Jang, S Serban, PS Frenette, GF Atweh, JL Gabrilove, C Miller 02-2010. Phase One Study of IVIg for Acute Pain Espisodes 4th Annual Sickle Cell Disease Research and Educational Symposium and Annual National Sickle Cell Scientific Meeting Hollywood Florida , ,